Structure

InChI Key NEEHYRZPVYRGPP-IYEMJOQQSA-L
Smile O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.O=C([O-])[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.[Ca+2]
InChI
InChI=1S/2C6H12O7.Ca/c2*7-1-2(8)3(9)4(10)5(11)6(12)13;/h2*2-5,7-11H,1H2,(H,12,13);/q;;+2/p-2/t2*2-,3-,4+,5-;/m11./s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C12H22CaO14
Molecular Weight 430.37
AlogP None
Hydrogen Bond Acceptor None
Hydrogen Bond Donor None
Number of Rotational Bond None
Polar Surface Area None
Molecular species None
Aromatic Rings None
Heavy Atoms None

Pharmacology

Action Mechanism of Action Reference
None Mineral supplement

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Osteoporosis 3 D010024 ClinicalTrials
Ovarian Hyperstimulation Syndrome 2 D016471 ClinicalTrials
Peripheral Nervous System Diseases 1 D010523 ClinicalTrials
Esophageal Neoplasms 1 D004938 ClinicalTrials

Related Entries

Parent

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
Metabolism and nutrition disorders
16.0
Endocrine disorders
12.0
General disorders and administration site conditions
12.0
Nervous system disorders
8.0
Renal and urinary disorders
8.0
Vascular disorders
8.0
Cardiac disorders
6.0
Hepatobiliary disorders
6.0
Musculoskeletal and connective tissue disorders
6.0
Respiratory, thoracic and mediastinal disorders
6.0
Infections and infestations
4.0
Skin and subcutaneous tissue disorders
4.0

Cross References

Resources Reference
CAS NUMBER 299-28-5
ChEBI 3309
ChEMBL CHEMBL2106119
DrugBank DB11126
EPA CompTox DTXSID2029618
FDA SRS SQE6VB453K
KEGG C08133
PubChem 9290
SureChEMBL SCHEMBL24132